Analyst (f/m/d) @ Wellington Partners Life Sciences
Analyst (f/m/d) @ Wellington Partners Life Sciences
Are you curious about how cutting-edge life science technologies become products that benefit patients? Would you like to become part of a venture firm, learn how to scout for new ideas, analyze technologies and business models, and create and support portfolio companies? If yes, then join wellingtonpartners as an Analyst in the Life Sciences Team.
We are looking for highly motivated additions to our life science investment team in Munich, with superb scientific and medical understanding and a strong desire to build a successful career in venture capital or related fields including the biotech/pharmaceutical/diagnostic/medical device industry. Successful applicants will join our team full-time either for an internship of at least 6 months or be directly considered for a permanent position.
Job Description
• Join the Investment team (full-time) in the Munich office.
• Document, screen and prioritize incoming deal flow of potential investment opportunities.
• Prepare and attend meetings with founders and management teams.
• Assist in the evaluation of investment opportunities through targeted research and benchmarking against standard of care.
• Prepare key analyses, e.g. compile information on disease areas, key product developments and competitor dynamics.
• Work with the team on consolidating key findings and forming the theses for prospective investments.
• Support the team on elements of the due diligence process as well as in the preparation of internal documentation for investment opportunities.
• Assist the team in general administration and in tasks arising from portfolio management, monitoring, and reporting.
Requirements
• A strong educational background in the Life Sciences or Medicine with above average exam grades is required (MSc / MD / PhD).
• Prior experience in business, bio-medical research or medicine is a plus.
• Affinity to financial analysis and evaluation of business models is a plus.
• Excellent written and verbal communication skills in English are required.
• Familiarity with standard office software (Word, Excel, PowerPoint) is needed.
• Munich location is required.
Personality
• Ambitious, hard-working, diligent personality and willingness to take responsibility.
• Curious, analytical, pro-active, self-motivated and eager to learn fast.
• Resourceful team player willing to support others to excel.
• Strong networker, outgoing person, that integrates well in multicultural environments.
Instructions
• Submit an application incl. a cover letter and CV to or use the Online Application form.
About
Based in Munich, wellingtonpartners is among the most successful pan-European Venture Capital firms. With currently more than € 600 million under management, we invest in early- to late-stage start-up companies throughout Europe that have the potential to become global leaders. Going forward we plan to further expand our investment activities in Life Sciences, an area where we have a leading position in the German-speaking countries and beyond.
Since 1998, Wellington Partners has invested in over 55 life science companies, including publicly listed firms such as Actelion (acquired by J&J), Oxford Immunotec (acquired by Perkin Elmer), immatics, 4SC, Carisma and ONWARD, as well as privately held companies such as Adrenomed, Aignostics, AMB, Amboss, Confo, Definiens (acquired by Medimmune/AstraZeneca), Dunad , eGenesis, invendo (acquired by Ambu), ImCheck, iOmx, Koa Health, Middle Peak Medical (acquired by Symetis/Boston Scientific), Minervax, MMI, mtm laboratories (acquired by Roche), nyra health, Perfect Vision (acquired by Bausch&Lomb), Quanta Dialysis Technologies, Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Seamless Therapeutics, Sidekick, SNIPR Biome, SphingoTec, STipe Therapeutics Symetis (acquired by Boston Scientific), Themis (acquired by MSD), TriCares and UroMems.
Investment Manager (f/m/d) @ Wellington Partners Life Sciences
Investment Manager (f/m/d) @ Wellington Partners Life Sciences
Are you curious about how cutting-edge life science technologies become products that benefit patients? Would you like to become part of a venture firm, learn how to scout for new ideas, analyze technologies and business models, and create and support portfolio companies? If yes, then join wellingtonpartners as an Investment Manager in the Life Sciences Team.
We are looking for highly motivated additions to our life science investment team in Munich, with superb scientific and medical understanding and a strong desire to build a successful career in venture capital or related fields including the biotech/pharmaceutical/diagnostic/medical device industry. Successful applicants will join our team full-time in the Munich office.
Job Description
• Join the Investment team (full-time) in the Munich office.
• Identify and evaluate life science investment opportunities for Wellington Partners.
• Work closely with and support the investment team on elements of the due diligence and task arising from new investments.
• Support the investment team in trade sales and IPO processes.
• Work with the team in general administration of the funds under management and in tasks arising from portfolio management, monitoring, and reporting.
• Develop a network of private and institutional investors, incubators, research organizations, consultants, and industry experts.
Requirements
• A strong educational background in Medicine or the Life Sciences with above average exam grades is required (MSc / MD / PhD).
• Previous work experience (2-4 years) in related industries is required.
• Previous experience in bio-medical research or medicine is a plus.
• Strong interest in investments, capital markets, business models and finance is needed.
• Excellent written and verbal communication skills in English are required.
• Familiarity with standard office software (Word, Excel, PowerPoint) is needed.
• Munich location is required.
Personality
• Ambitious, hard-working, diligent personality and willingness to take responsibility.
• Curious, analytical, pro-active, self-motivated and eager to learn fast.
• Resourceful team player willing to support others to excel.
• Strong networker, outgoing person, that integrates well in multicultural environments.
Instructions
• Submit an application incl. a cover letter and CV to or use the Online Application form.
About
Based in Munich, wellingtonpartners is among the most successful pan-European Venture Capital firms. With currently more than € 600 million under management, we invest in early- to late-stage start-up companies throughout Europe that have the potential to become global leaders. Going forward we plan to further expand our investment activities in Life Sciences, an area where we have a leading position in the German-speaking countries and beyond.
Since 1998, Wellington Partners has invested in over 55 life science companies, including publicly listed firms such as Actelion (acquired by J&J), Oxford Immunotec (acquired by Perkin Elmer), immatics, 4SC, Carisma and ONWARD, as well as privately held companies such as Adrenomed, Aignostics, AMB, Amboss, Confo, Definiens (acquired by Medimmune/AstraZeneca), Dunad , eGenesis, invendo (acquired by Ambu), ImCheck, iOmx, Koa Health, Middle Peak Medical (acquired by Symetis/Boston Scientific), Minervax, MMI, mtm laboratories (acquired by Roche), nyra health, Perfect Vision (acquired by Bausch&Lomb), Quanta Dialysis Technologies, Rigontec (acquired by MSD), Sapiens (acquired by Medtronic), Seamless Therapeutics, Sidekick, SNIPR Biome, SphingoTec, STipe Therapeutics Symetis (acquired by Boston Scientific), Themis (acquired by MSD), TriCares and UroMems.
Wellington Partners promotes Johannes Fischer and Varun Gupta to Partner
Wellington Partners promotes Johannes Fischer and Varun Gupta to Partner
November 06, 2023
Munich, Germany – Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, today announced the promotion of Dr. Johannes Fischer and Dr. Varun Gupta to Partner, effective immediately.
Johannes joined Wellington in 2020 supporting the firm’s existing medical device and digital health portfolio. For the past years, he has been the driving force behind Wellington’s renewed strategy in digital health and increasing activity in the cross-sections of traditional healthcare and medical research. He has been instrumental to the investments and ongoing management of several portfolio companies including Sidekick Health, aignostics, MMI and nyra health. Johannes began his professional career as consultant at the life sciences practice of L.E.K. Consulting, where he managed and executed numerous market access, performance enhancement and M&A projects for life science companies. He holds an MSc in Biochemistry, a PhD in Biotechnology and a Medical Doctorate from Technical University, Munich.
Varun has been an integral part of Wellington’s investment team since 2018. He has taken a leading role in defining the firm’s early-stage investment strategy in biotech and has spearheaded the active deal sourcing in the DACH region. Over the past few years, Varun has led the investments in and supported several biopharma portfolio companies, including Dunad Therapeutics, Seamless Therapeutics, Confo Therapeutics, STipe Therapeutics and MinervaX. Prior to joining Wellington, Varun interned at Ysios Capital in Barcelona and assisted the investment team at Forbion in Amsterdam/Naarden. He was awarded a PhD with summa cum laude in Neuroscience from the Free University of Berlin and holds an MBA from IESE Business School in Barcelona.
Regina Hodits, Managing Partner of Wellington Partners, commented: “We are grateful for Johannes and Varun’s significant contribution during the past years. Their efforts have been critical in expanding our investment activities to new areas like targeted protein degradation and digital care and rehabilitation, which we believe will significantly impact patients’ lives in the future. Their profiles have proven to perfectly complement the investment efforts at Wellington Partners.”
Rainer Strohmenger, Managing Partner of Wellington Partners, commented: “Since joining Wellington, Johannes and Varun have rapidly developed to become valuable members of our Life Sciences focused team and internationally recognized investment professionals in our industry. We congratulate them on the well-deserved promotion to Partner.”
“We are confident of their significant abilities to identify highly potent and differentiated life science companies and their capabilities to develop these into profitable exits for the investing funds”, added Karl Naegler, Managing Partner of Wellington Partners.
About Wellington Partners
Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totalling more than €1.2 billion, thereof €590 million committed to life sciences, Wellington Partners has been actively supporting world class private companies translating true innovation into successful businesses with exceptional growth. To date, Wellington Partners has invested in 58 innovative life science companies, including 4SC (FSE: VSC), Actelion (acquired by J&J), Carisma Therapeutics (NASDAQ: CARM), Definiens (acquired by AZ), immatics (Nasdaq: IMTX), invendo (acquired by Ambu), MTM Laboratories (acquired by Roche/Ventana), Onward Medical (Euronext: ONWD), Oxford Immunotec (acquired by PerkinElmer), Rigontec (acquired by MSD), Symetis (acquired by Boston Scientific), and Themis (acquired by MSD).
For more information, please visit: https://wellington-partners.com/
Contact details
Wellington Partners
Dr. Regina Hodits, Managing Partner
Dr. Rainer Strohmenger, Managing Partner
Dr. Karl Naegler, Managing Partner
Dr. Johannes Fischer, Partner
Dr. Varun Gupta, Partner
Via Karina Schuster
+49 (0) 89 219941-20
For media enquiries
MC Services AG
Dr. Regina Lutz / Kaja Skorka
+49 (0) 89 210228-25
